CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $716,602 | -33.9% | 1,651,536 | 0.0% | 0.00% | – |
Q4 2022 | $1,083,738 | -23.6% | 1,651,536 | +0.1% | 0.00% | – |
Q3 2022 | $1,419,000 | +47.4% | 1,650,704 | -5.9% | 0.00% | – |
Q2 2022 | $963,000 | -50.5% | 1,754,153 | 0.0% | 0.00% | – |
Q1 2022 | $1,947,000 | -39.5% | 1,754,153 | -6.2% | 0.00% | – |
Q4 2021 | $3,216,000 | -26.8% | 1,870,363 | +30.6% | 0.00% | – |
Q3 2021 | $4,396,000 | -20.8% | 1,432,029 | +0.6% | 0.00% | – |
Q2 2021 | $5,552,000 | +19.2% | 1,423,532 | -14.7% | 0.00% | – |
Q1 2021 | $4,657,000 | -8.6% | 1,669,139 | +0.2% | 0.00% | – |
Q4 2020 | $5,095,000 | -51.3% | 1,665,180 | -3.2% | 0.00% | – |
Q3 2020 | $10,454,000 | +57.7% | 1,719,420 | +53.3% | 0.00% | – |
Q2 2020 | $6,629,000 | +93.5% | 1,121,604 | -13.2% | 0.00% | – |
Q1 2020 | $3,425,000 | -2.5% | 1,292,807 | +0.1% | 0.00% | – |
Q4 2019 | $3,513,000 | -77.6% | 1,291,625 | -0.3% | 0.00% | -100.0% |
Q3 2019 | $15,699,000 | +22.4% | 1,295,205 | +15.6% | 0.00% | – |
Q2 2019 | $12,828,000 | – | 1,120,334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
COLONY GROUP LLC | 102,884 | $44 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 727 | $316 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 91 | $39 | 0.00% |